Amplicore Competitors and Similar CompaniesClear all
Amplicore's competitors and similar companies include Tonix Pharmaceuticals, Wuhan Orient Honest Medical, Impel Pharmaceuticals and Yuanyi (Shandong) Gene Technology.
 Amplicore Amplicore is a developer of injectable therapeutics for degenerative musculoskeletal disorders. |  Tonix Pharmaceuticals Tonix Pharmaceuticals develops pharmaceutical products for central nervous system disorders. |  Wuhan Orient Honest Medical Wuhan Orient Honest Medical is a company that develops and manufactures pharmaceutical products. |  Impel Pharmaceuticals Impel Pharmaceuticals (formerly known as Impel NeuroPharma) is a pharmaceutical company that develops and commercializes therapies for patients suffering from central nervous system diseases. |  Yuanyi (Shandong) Gene Technology Yuanyi (Shandong) Gene Technology Co., Ltd. (源宜 基因科技股份有限公司) is specialized in providing cutting-edge research technologies in life sciences. | |
Founding Date | Founding Date 2018 | Founding Date 2007 | Founding Date 2001 | Founding Date 2008 | Founding Date 2009 |
Type | Type Private | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Mason, US HQ | Locations Chatham, US HQ Montréal, CA Dublin, IE Dartmouth, US New York, US San Diego, US | Locations 武汉市, CN HQ | Locations Seattle, US HQ | Locations HQ |
Employees | Employees 9 | Employees 1633% increase | Employees N/A | Employees 6710% increase | Employees N/A |
Valuation ($) | Valuation ($) N/A | Valuation ($) 23.5 m | Valuation ($) N/A | Valuation ($) 5.8 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $13.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $12.7m (FY, 2022) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $6.6m (FY, 2025) | Cost of goods N/A | Cost of goods $6.5m (FY, 2022) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $6.5m (FY, 2025) | Gross profit N/A | Gross profit $6.2m (FY, 2022) | Gross profit N/A |
Net income | Net income N/A | Net income ($124m) (FY, 2025) | Net income N/A | Net income ($106.3m) (FY, 2022) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 4m | Total funding raised $ 15.5m | Total funding raised N/A | Total funding raised $ 108.1m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Tonix Pharmaceuticals
HQ
Chatham, US
Employees
16↑ 33% increase
Tonix Pharmaceuticals develops pharmaceutical products for central nervous system disorders.
View companyWuhan Orient Honest Medical
HQ
武汉市, CN
Wuhan Orient Honest Medical is a company that develops and manufactures pharmaceutical products.
View companyImpel Pharmaceuticals
HQ
Seattle, US
Employees
67↑ 10% increase
Impel Pharmaceuticals (formerly known as Impel NeuroPharma) is a pharmaceutical company that develops and commercializes therapies for patients suffering from central nervous system diseases.
View companyYuanyi (Shandong) Gene Technology
HQ
Yuanyi (Shandong) Gene Technology Co., Ltd. (源宜 基因科技股份有限公司) is specialized in providing cutting-edge research technologies in life sciences.
View company